27 agosto 2014
A potential new treatment approach for hereditary neurological disorder, the incurable Charcot-Marie-Tooth disease, has been found by researchers. Patients with Charcot-Marie-Tooth disease type 1A harbour an extra copy of the PMP22 gene which leads to the overproduction of the peripheral myelin protein 22 (PMP22), a key component of myelin.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/E0dUJxj_OUM/140827111936.htm
